Episodes (Page 23)
✨
Key takeaways from LSX World Congress USA.
Eric Boyda
Tony Shi
✨
Pioneer Alan Aspuru-Guzik discusses self-driving labs.
Alan Aspuru-Guzik
✨
Pfizer withdraws sickle cell drug Oxbryta.
✨
Experts discuss challenges in Antibody-Drug Conjugate (ADC) development.
Matthieu Culie
Simone Secchi
✨
Radiopharmaceutical therapies are seeing a resurgence in oncology.
Dana Gheorghe
✨
Discussing Health-Related Quality of Life (HRQoL) in clinical trials.
Mai Yee Mishir
Sally-Ann McDowell
✨
Neil D’Souza discusses digital tools for sustainable personal care.
✨
Exploring the therapeutic potential of the tumor microenvironment (TME).
✨
FDA scrutinizes celebrity drug endorsements, citing Serena Williams ad.
✨
Generics Bulletin team reviews recent industry events.
✨
Chinese pharmaceutical companies are expanding global Phase III trials to Japan.
✨
Johnson & Johnson CEO discusses interest in differentiated obesity assets.
✨
J&J interested in differentiated obesity assets; Kerendia success in heart failure.
✨
Rare pediatric disease PRV deadline approaches; potential Makena compounding ban.
✨
ADC dealmaking continues; cell therapies in Japan; Pfizer's digital platform.
✨
New FDA developments in AI regulation for drugs.
✨
Digital therapeutics for depression, Alzheimer's, and brain injury recovery.
✨
Exploring the emerging opportunity of postbiotics in consumer health.
Sonja Nodland
✨
CMS price reveal better than expected; Zepbound diabetes risk data.
✨
Discussing the future role of psychedelics in mental health treatment.